Page last updated: 2024-10-26

etidronate and Ankylosing Vertebral Hyperostosis with Tylosis

etidronate has been researched along with Ankylosing Vertebral Hyperostosis with Tylosis in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fulton, JD1

Other Studies

1 other study available for etidronate and Ankylosing Vertebral Hyperostosis with Tylosis

ArticleYear
Analgesic use of etidronate in Forrestier's disease.
    Lancet (London, England), 1992, Nov-21, Volume: 340, Issue:8830

    Topics: Aged; Etidronic Acid; Humans; Hyperostosis, Diffuse Idiopathic Skeletal; Male; Palliative Care

1992